While the U.S. stock market has rebounded, the combination of the Trump tariffs, a volatile dollar and an erratic bond market ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...

Panelist discusses how new all-oral combination regimens are transforming the treatment landscape by addressing unmet needs ...

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML ...

Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body mass while still trimming pounds.

After the announcement, Sequans' stock (SQNS) climbed over 43% in 24 hours, peaking at $1.81 pre-market. By contrast, Bitcoin ...

In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, discuss how to increase patient interest in elective lifestyle and cosmetic ophthalmic procedures now that ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.

--Arvinas, Inc., a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today presented data from preclinical combination studies of ...